参考文献/References:
[1] 张彤格,贾 玫.脂蛋白相关性磷脂酶A2与冠心病相关性研究进展[J].中华检验医学杂志,2015,38(7):493-497.
Zhang TG,Jia M.Lipoprotein-associated phospholi-pase A2 and coronary heart disease[J].Chin J Lab Med,2015,38(7):493-497.
[2] 赵 佳,姚创利,左 林,等.冠心病患者血清同型半胱氨酸对血脂和锰超氧化物歧化酶的影响[J].现代检验医学杂志,2015,30(5):44-45,49.
Zhao J,Yao CL,Zuo L,et al.Effect of homocysteine on bloodlipid and manganese superoxide dismutase in patients with coronary heart disease[J].J Mod Lab Med,2015,30(5):44-45,49.
[3] 姚创利,赵 佳,黎 阳,等.锰超氧化物歧化酶9 Ala/Val基因多态性对冠心病的影响[J].现代检验医学杂志,2015,30(2):1-2,6.
Yao CL,Zhao J,Li Y,et al.Effect of manganese superoxide dismutase 9 Ala/Val gene polymorphism on coronary heart disease[J].J Mod Lab Med,2015,30(2):1-2,6.
[4] Epps KC,Wilensky RL.Lp-PLA2-a novol risk factor for high risk coronary and carotid artery disease [J].J Intern Med,2011,269(1):94-106.
[5] Six DA, Dennis EA. The expanding superfamily of phospholipase A(2)enzymes:classification and characterization[J].Biochim Biophys Acta,2000,1488(1/2):1-19.
[6] Silve IT,Mello AP,Damasceno NR.Antioxidant and inflammatory aspects oflipoprotein-associated phospholipase A2(Lp-PLA2):a review[J].Lipids Health Dis,2011,10(1):170.
[7] 徐如林,蔡安平,麦炜颐.脂蛋白相关性磷脂酶A2:一种新型的,具有前景的评估心血管危险的生化标记物[J].新医学,2014,45(4):211-217.
Xu RL, Cai AP, Mai WY.Lipoprotein associated phospholipase A2:anovel,promising biochemical marker for evaluating cardiovascular risk[J].NewMedicine,2014,45(4):211-217.
[8] Sachdeva A,Cannon CP,Deedwania PC,et al.Lipid levels in patients hospitalized with coronary artery disease:an analysis of 136 905 hospitalizations in Get with the Guidelines[J].Am Heart J,2009,157(1):111-117,e2.
[9] 张伟伟,张一娜,迟啸威,等.脂蛋白相关性磷脂酶A2在冠心病中的研究进展[J].中西医结合心脑血管病杂志,2012,10(4):469-471.
Zhang WW,Zhang YN,Chi XW,et al.Research progress of lipoproteinassociated phospholipase A2 in coronary heart disease[J].Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease,2012,10(4):469-471.
相似文献/References:
[1]洪骏,王锋,印中鹏,等.冠心病患者血浆纤维蛋白原与脂蛋白相关磷脂酶A2水平[J].现代检验医学杂志,2015,30(05):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
HONG Jun,WANG Feng,YIN Zhong-peng,et al.Levels of Plasma Lipoprotein Associated Phospholipase A2
and Fibrinogen in Patients with Coronary Artery Disease[J].Journal of Modern Laboratory Medicine,2015,30(01):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
[2]姚创利,黎 阳,鲁旭娟,等.超氧化物歧化酶及其同工酶和超敏C-反应蛋白与冠心病的关系[J].现代检验医学杂志,2016,31(05):73.[doi:10.3969/j.issn.1671-7414.2016.05.019]
YAO Chuang-li,LI Yang,LU Xu-juan,et al.Relationship of Superoxide Dismutase Isoenzyme and High
Sensitive C-Reactive Protein with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2016,31(01):73.[doi:10.3969/j.issn.1671-7414.2016.05.019]
[3]文关良,剌 梅.脂蛋白相关磷脂酶A2在颈动脉斑块性脑梗死中的临床意义[J].现代检验医学杂志,2017,32(02):117.[doi:10.3969/j.issn.1671-7414.2017.02.032]
WEN Guan-liang,LA Mei.Clinical Study of LP-PLA2
in Carotid Plaques Cerebral Infarction Patients[J].Journal of Modern Laboratory Medicine,2017,32(01):117.[doi:10.3969/j.issn.1671-7414.2017.02.032]
[4]王 坤,贾兴旺,董 矜,等.血清脂蛋白相关磷脂酶A2和胱抑素C联合检测对SLE患者并发狼疮性肾炎的风险评估[J].现代检验医学杂志,2017,32(04):6.[doi:10.3969/j.issn.1671-7414.2017.04.002]
WANG Kun,JIA Xing-wang,DONG Jin,et al.Risk Assessment of Combined Detection of Lipoprotein Associated
Phospholipase A2 and Cystatin C for Lupus Nephritis
in Patients with Systemic Lupus Erythematosus[J].Journal of Modern Laboratory Medicine,2017,32(01):6.[doi:10.3969/j.issn.1671-7414.2017.04.002]
[5]李 薪,魏力强.2型糖尿病患者血清中脂蛋白相关磷脂酶A2检测的临床意义[J].现代检验医学杂志,2017,32(06):85.[doi:10.3969/j.issn.1671-7414.2017.06.001]
LI Xin,WEI Li-qiang.Clinical Significance of Detection of Lipoprotein Associated
Phospholipase A2 in Serum of Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2017,32(01):85.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[6]王丹晨,侯立安,国秀芝,等.改良后的长春恒晓脂蛋白相关磷脂酶A2活性检测试剂性能验证[J].现代检验医学杂志,2018,33(04):134.[doi:10.3969/j.issn.1671-7414.2018.04.037]
WANG Dan-chen,HOU Li-an,GUO Xiu-zhi,et al.Performance Verification of Improved Lipoprotein-associated
Phospholipase A2 Detection Reagent of Changchun Hengxiao Co.,Ltd.[J].Journal of Modern Laboratory Medicine,2018,33(01):134.[doi:10.3969/j.issn.1671-7414.2018.04.037]
[7]马丽丽a,刚 君b,吕 静.妊娠并发甲减患者血清脂蛋白相关磷脂酶A2水平与母婴预后的相关性分析[J].现代检验医学杂志,2021,36(06):183.[doi:10.3969/j.issn.1671-7414.2021.06.040]
MA Li-Li,Lü Jing,GANG Jun.Correlation between Serum Lipoprotein Associated Phospholipase A2 Level and Maternal and Infant Prognosis in Pregnant Women with Hypothyroidism[J].Journal of Modern Laboratory Medicine,2021,36(01):183.[doi:10.3969/j.issn.1671-7414.2021.06.040]
[8]张东方,王 茜,李 娟,等.高龄妊娠期糖尿病患者血清miR-351，FGF19 和LP-PLA2 表达水平及其与产后糖代谢异常的相关性研究[J].现代检验医学杂志,2023,38(01):66.[doi:10.3969/j.issn.1671-7414.2023.01.013]
ZHANG Dong-fang,WANG Qian,LI Juan,et al.Serum miR-351, FGF19 and LP-PLA2 Expression Levels in Elderly Patients with Gestational Diabetes Mellitus and Their Correlation with Abnormal Postpartum Glucose Metabolism[J].Journal of Modern Laboratory Medicine,2023,38(01):66.[doi:10.3969/j.issn.1671-7414.2023.01.013]